#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5168032	Binding	Binding affinity to MBP-tagged human recombinant AF9 (487 to 568 residues) incubated for 40 mins by measuring fluorescence polarization by microplate reader method	Homo sapiens	14	ALA5154930	single protein format	Scientific Literature
2.	ALA5168033	Binding	Binding affinity to MBP-tagged human recombinant ENL (489 to 559 residues) incubated for 40 mins by measuring fluorescence polarization by microplate reader method	Homo sapiens	14	ALA5154930	single protein format	Scientific Literature
3.	ALA5168034	Functional	Anticancer activity against human MOLM-13 cells harbouring MLL-AF9 assessed as inhibition of cell growth treated for 8 days measured by CCK-8 kit method	Homo sapiens	12	ALA5154930	cell-based format	Scientific Literature
4.	ALA5168035	Functional	Anticancer activity against human KOPN-8 cells harbouring MLL-ENL assessed as inhibition of cell growth treated for 8 days measured by CCK-8 kit method	Homo sapiens	12	ALA5154930	cell-based format	Scientific Literature
5.	ALA5168036	Functional	Anticancer activity against human RS4-11 cells assessed as inhibition of cell growth treated for 8 days measured by CCK-8 kit method	Homo sapiens	12	ALA5154930	cell-based format	Scientific Literature
6.	ALA5168037	Functional	Anticancer activity against human MV4-11 cells assessed as inhibition of cell growth treated for 8 days measured by CCK-8 kit method	Homo sapiens	12	ALA5154930	cell-based format	Scientific Literature
7.	ALA5168038	Functional	Anticancer activity against human K562 cells assessed as inhibition of cell growth treated for 8 days measured by CCK-8 kit method	Homo sapiens	12	ALA5154930	cell-based format	Scientific Literature
8.	ALA5168041	Functional	Anticancer activity against human MOLM-13 cells harbouring MLL-AF9 assessed as inhibition of cell growth treated for 4 days measured by CCK-8 kit method	Homo sapiens	3	ALA5154930	cell-based format	Scientific Literature
9.	ALA5168042	Functional	Anticancer activity against human MOLM-13 cells harbouring MLL-AF9 assessed as inhibition of cell growth treated for 5 days measured by CCK-8 kit method	Homo sapiens	3	ALA5154930	cell-based format	Scientific Literature
10.	ALA5168043	Functional	Anticancer activity against human MOLM-13 cells harbouring MLL-AF9 assessed as inhibition of cell growth treated for 6 days measured by CCK-8 kit method	Homo sapiens	3	ALA5154930	cell-based format	Scientific Literature
11.	ALA5168044	Functional	Anticancer activity against human MOLM-13 cells harbouring MLL-AF9 assessed as inhibition of cell growth treated for 7 days measured by CCK-8 kit method	Homo sapiens	3	ALA5154930	cell-based format	Scientific Literature
12.	ALA5168045	Functional	Anticancer activity against human MOLM-13 cells harbouring MLL-AF9 assessed as inhibition of cell growth treated for 9 days measured by CCK-8 kit method	Homo sapiens	3	ALA5154930	cell-based format	Scientific Literature
13.	ALA5168046	ADME	Apparent permeability across apical to basolateral side in human Caco-2 cells	Homo sapiens	5	ALA5154930	cell-based format	Scientific Literature
14.	ALA5168047	ADME	Stability in human plasma assessed as compound remaining measured upto 1440 mins by HPLC analysis	Homo sapiens	5	ALA5154930	cell-free format	Scientific Literature